Clinical Trials on Focal Lipoid Glomerulosclerosis in South Africa
Total 361 results
-
Mallinckrodt ARD LLCCompletedIdiopathic Focal Segmental GlomerulosclerosisUnited States, Argentina, Turkey, Peru, Australia, Chile, Mexico
-
Dimerix Bioscience Pty LtdIqvia Pty LtdCompletedFocal Segmental GlomerulosclerosisAustralia
-
NYU Langone HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedFocal Segmental GlomerulosclerosisUnited States, Canada
-
Kaneka Medical America LLCRecruitingFocal Segmental GlomerulosclerosisUnited States
-
Kaneka Medical America LLCRecruitingFocal Segmental GlomerulosclerosisUnited States
-
Astellas Pharma Global Development, Inc.Kyowa Kirin Co., Ltd.CompletedKidney Transplantation | Primary Focal Segmental Glomerulosclerosis (FSGS)United States, Canada
-
Vertex Pharmaceuticals IncorporatedCompletedGlomerulosclerosis, Focal SegmentalUnited States, France, United Kingdom, Puerto Rico
-
Travere Therapeutics, Inc.Active, not recruitingFocal Segmental GlomerulosclerosisUnited States, Australia, Belgium, Croatia, Estonia, Germany, Hong Kong, Italy, Korea, Republic of, Poland, Portugal, Spain, Taiwan, United Kingdom, Argentina, Brazil, Canada, Czechia, Denmark, France, New Zealand, Sweden
-
Goldfinch Bio, Inc.TerminatedKidney Diseases | Urologic Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Complications | Diabetic Nephropathies | Glomerulonephritis | Nephritis | Glomerulosclerosis, Focal Segmental | Nephrosis | Nephrosis, LipoidUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitationFocal Segmental Glomerulosclerosis | Minimal Change Disease | Membranous Nephropathy | Nephrotic Syndrome in Children | FSGS | MCD | Minimal Change Nephrotic Syndrome | MCD - Minimal Change DiseaseUnited States
-
Boehringer IngelheimRecruitingKidney Disease, ChronicUnited States, Belgium, Australia, Spain, Germany, France, Italy, New Zealand, United Kingdom, China, Ireland
-
AstraZenecaCompletedUndertreatment of HypercholesterolaemiaSouth Africa
-
AstraZenecaCompleted
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...RecruitingGlomerulosclerosis, Focal Segmental | Membranous Nephropathy | Minimal Change Disease (MCD)United States, Canada
-
PfizerCompletedGaucher DiseaseIsrael, Paraguay, South Africa
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
PfizerCompletedGaucher DiseaseIsrael, South Africa, Paraguay
-
The Medicines CompanyCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa
-
University of PennsylvaniaUniversity of Amsterdam; University of Cape Town; University of Witwatersrand...RecruitingHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa
-
PfizerCompletedHypercholesterolemia, FamilialCanada, United States, South Africa
-
Arrowhead PharmaceuticalsActive, not recruitingHomozygous Familial HypercholesterolemiaAustralia, Canada, United States, South Africa
-
Sydney Children's Hospitals NetworkUnknownAppendicitis | Acute Focal AppendicitisAustralia
-
Neurocrine BiosciencesCompletedFocal Onset Seizure | Focal Onset EpilepsySpain, Belgium, Czechia, France, Italy, Australia, Hungary, United Kingdom
-
LIB Therapeutics LLCMedpace, Inc.CompletedHeterozygous Familial HypercholesterolemiaUnited States, Israel, Norway, South Africa, Turkey
-
Aegerion Pharmaceuticals, Inc.CompletedFamilial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
BiogenCompletedEpilepsy, Focal Seizures, Partial SeizuresUnited States
-
Cerebral Therapeutics LLCTerminatedFocal EpilepsyIsrael, Australia
-
Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products DevelopmentCompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, South Africa
-
SanofiTerminatedHypercholesterolemiaUnited States, France, Canada, Russian Federation, Ukraine, Netherlands, Bulgaria, Belgium, Czech Republic, Israel, Slovakia, Australia, South Africa
-
Novartis PharmaceuticalsCompletedA Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)Homozygous Familial HypercholesterolemiaHong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
-
Medical University of South CarolinaEnrolling by invitationAnesthesia, Local | Dental Anxiety | Child Behavior | Therapy AnimalsUnited States
-
Cerebral Therapeutics LLCTerminated
-
Biohaven Therapeutics Ltd.RecruitingFocal EpilepsyUnited States
-
TaiGen Biotechnology Co., Ltd.CompletedDiabetic Foot InfectionsTaiwan, United States, South Africa, Thailand
-
LIB Therapeutics LLCCompletedHomozygous Familial HypercholesterolemiaUnited States, Israel, Norway, South Africa, Turkey, India
-
Thorne Research Inc.Indena S.p.ATerminated
-
LIB Therapeutics LLCMedpace, Inc.Enrolling by invitationFamilial Hypercholesterolemia | Elevated Cholesterol | Cardiovascular Disease With Mention of ArteriosclerosisUnited States, Israel, Norway, South Africa, Turkey, India
-
PfizerCompletedGaucher DiseaseUnited States, Chile, United Kingdom, Israel, Canada, Spain, South Africa, Italy
-
PfizerCompletedGaucher DiseaseChile, United Kingdom, Canada, Spain, Israel, United States, Australia, South Africa
-
NYU Langone HealthThe Epilepsy Study ConsortiumCompleted
-
Kastle Therapeutics, LLCIonis Pharmaceuticals, Inc.CompletedMetabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Hyperlipoproteinemias | Lipid Metabolism, Inborn Errors | Hyperlipoproteinemia Type II | Metabolic... and other conditionsUnited States, Taiwan, Brazil, Canada, South Africa, United Kingdom, Singapore
-
Novartis PharmaceuticalsTerminatedFamilial Chylomicronemia Syndrome (FCS) (HLP Type I)South Africa, Germany, United Kingdom, France, United States, Canada, Netherlands
-
Xenon Pharmaceuticals Inc.Worldwide Clinical TrialsRecruitingFocal Onset SeizuresUnited States, Spain, Australia, Poland, Canada, Bulgaria, Italy, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaNorway, Russian Federation, Sweden, South Africa, Czechia, United States, Canada, France, Netherlands, Spain
-
Xenon Pharmaceuticals Inc.Novotech Health Holdings Pte. Ltd.Active, not recruitingFocal EpilepsySpain, United States, Ukraine, Canada, United Kingdom, Germany, Georgia, Italy, Moldova, Republic of
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, Israel, South Africa, United States
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Brazil, Australia, Italy, Sweden, Malaysia, Singapore, Taiwan, Mexico, Denmark, Korea, Republic of, Hong Kong, South Africa
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedDepression | Opioid Abuse | Opioid-use DisorderUnited States
-
Medical University of South CarolinaCompleted
-
Novartis PharmaceuticalsCompletedFamilial Chylomicronemia Syndrome (FCS)South Africa, Spain, France, Germany, United Kingdom, United States, Canada, Netherlands